Search for: "DOW PHARMACEUTICAL SCIENCES, INC."
Results 101 - 120
of 130
Sort by Relevance
|
Sort by Date
4 Jul 2010, 4:16 pm
Merrell Dow Pharmaceuticals, Inc., 509 US 579 which, in federal courts, displaced the Frye general acceptance standard based upon the Federal Rules of Evidence. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
8 Apr 2010, 9:27 am
Patrick Gruber, CEO, Gevo, Inc., recognizing his accomplishments in creating and commercializing a new plastic made from annually renewable resources. [read post]
22 Mar 2010, 4:13 am
Dow Agro Sciences, et al. [read post]
15 Mar 2010, 2:09 pm
BIC USA, Inc., 136 F.Supp.2d 196, 207-208 (S.D.N.Y. 2000) (Consumer Product Safety Commission) (“The CPSC regulations establish general, rudimentary and minimal requirements. [read post]
23 Jan 2010, 6:53 pm
The first agreement was with Hologic Inc., a Bedford, Mass. [read post]
15 Dec 2009, 1:56 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993)]). [read post]
26 Oct 2009, 6:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
26 Oct 2009, 5:25 am
Medico (Filewrapper) BPAI finds claim indefinite and not directed to patentable subject under Bilski: Ex parte Hemmat (GRAY On Claims) District Court N D Illinois: KSR obviousness does not require prior art from the same field: Se-Kure Controls, Inc v Diam USA, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas finds plaintiff has standing; agreement transfers ownership and simultaneously a conditional purchase by transferor from transferee: Balsam Coffee… [read post]
9 Jul 2009, 4:54 am
Merrrell Dow Pharmaceuticals, Inc., 509 U .S. 579 (1993). [read post]
27 Mar 2009, 7:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)). [read post]
24 Mar 2009, 11:54 am
Merrell Dow Pharmaceuticals was a U.S. [read post]
7 Feb 2009, 10:24 pm
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993); see also Weisgram v. [read post]
22 Jul 2008, 10:42 am
Merrell Dow Pharms. [read post]
20 Jul 2008, 2:00 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)).Now Frye is a more conservative test. [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
23 May 2008, 10:17 pm
Philip Morris USA, Inc., 142 P.3d 1079 (Or. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
